Latest Insider Transactions at Diversicare Healthcare Services, Inc. (DVCR)
This section provides a real-time view of insider transactions for Diversicare Healthcare Services, Inc. (DVCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Diversicare Healthcare Services, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Diversicare Healthcare Services, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2021
|
Ben R Leedle Jr Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,048
-100.0%
|
$80,480
$10.1 P/Share
|
|
Nov 19
2021
|
Leslie K. Morgan Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
555,438
-100.0%
|
$5,554,380
$10.1 P/Share
|
|
Nov 19
2021
|
Leslie K. Morgan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,048
-100.0%
|
$80,480
$10.1 P/Share
|
|
Nov 19
2021
|
Robert A Mccabe Jr Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,219
-100.0%
|
$132,190
$10.1 P/Share
|
|
Nov 19
2021
|
Chad A. Mc Curdy Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,260,100
-100.0%
|
$12,601,000
$10.1 P/Share
|
|
Nov 19
2021
|
Chad A. Mc Curdy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,757
-100.0%
|
$247,570
$10.1 P/Share
|
|
Nov 19
2021
|
Richard M Brame Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,700
-100.0%
|
$27,000
$10.1 P/Share
|
|
Nov 19
2021
|
Richard M Brame Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,831
-100.0%
|
$528,310
$10.1 P/Share
|
|
Nov 19
2021
|
Robert Z Hensley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,995
-100.0%
|
$509,950
$10.1 P/Share
|
|
Nov 19
2021
|
Rebecca Bodie Executive VP & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,295
-100.0%
|
$352,950
$10.1 P/Share
|
|
Nov 19
2021
|
Kerry D. Massey Executive V.P. & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,792
-100.0%
|
$427,920
$10.1 P/Share
|
|
Nov 19
2021
|
James Reed Mc Knight Jr. CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
243,423
-100.0%
|
$2,434,230
$10.1 P/Share
|
|
Nov 03
2021
|
James Reed Mc Knight Jr. CEO and President |
SELL
Bona fide gift
|
Direct |
55,000
-18.43%
|
-
|
|
Sep 08
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-6.59%
|
$225,000
$9.65 P/Share
|
|
Sep 07
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
70,000
-19.51%
|
$630,000
$9.66 P/Share
|
|
Sep 03
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,000
-9.27%
|
$540,000
$9.7 P/Share
|
|
Sep 02
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-12.69%
|
$900,000
$9.73 P/Share
|
|
Sep 01
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-13.37%
|
$900,000
$9.76 P/Share
|
|
Aug 31
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-12.64%
|
$900,000
$9.75 P/Share
|
|
Aug 30
2021
|
Osmium Partners, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
47,950
-5.17%
|
$431,550
$9.74 P/Share
|
|
Mar 16
2021
|
Ben R Leedle Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+19.9%
|
-
|
|
Mar 16
2021
|
Leslie K. Morgan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+19.9%
|
-
|
|
Mar 16
2021
|
Robert A Mccabe Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+13.14%
|
-
|
|
Mar 16
2021
|
Chad A. Mc Curdy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.47%
|
-
|
|
Mar 16
2021
|
Richard M Brame Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.65%
|
-
|
|
Mar 16
2021
|
Robert Z Hensley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+3.77%
|
-
|
|
Mar 16
2021
|
Kerry D. Massey Executive V.P. & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.96%
|
-
|
|
Mar 16
2021
|
Rebecca Bodie Executive VP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.17%
|
-
|
|
Mar 16
2021
|
James Reed Mc Knight Jr. CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+7.73%
|
-
|
|
Mar 13
2021
|
Ben R Leedle Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.25%
|
-
|
|
Mar 13
2021
|
Leslie K. Morgan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.25%
|
-
|
|
Mar 13
2021
|
Robert A Mccabe Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.13%
|
-
|
|
Mar 13
2021
|
Chad A. Mc Curdy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
57
+0.25%
|
-
|
|
Mar 13
2021
|
Richard M Brame Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19
+0.04%
|
-
|
|
Mar 13
2021
|
Robert Z Hensley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19
+0.04%
|
-
|
|
Mar 13
2021
|
Kerry D. Massey Executive V.P. & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,708
-7.5%
|
$14,124
$3.75 P/Share
|
|
Mar 13
2021
|
Rebecca Bodie Executive VP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-6.23%
|
$3,051
$3.75 P/Share
|
|
Mar 13
2021
|
James Reed Mc Knight Jr. CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,129
-0.93%
|
$30,387
$3.75 P/Share
|
|
Mar 13
2021
|
James Reed Mc Knight Jr. CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,340
+1.81%
|
-
|
|
Jan 11
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,502
+2.32%
|
$40,506
$3.85 P/Share
|
|
Jan 08
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,318
+2.51%
|
$42,954
$3.62 P/Share
|
|
Jan 07
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,957
+3.83%
|
$92,871
$3.56 P/Share
|
|
Jan 05
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
114,063
+13.25%
|
$342,189
$3.13 P/Share
|
|
Jan 04
2021
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,800
+0.6%
|
$7,600
$2.95 P/Share
|
|
Dec 31
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,778
+2.98%
|
$41,556
$2.66 P/Share
|
|
Nov 11
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,919
+0.76%
|
$11,757
$3.45 P/Share
|
|
Nov 09
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,200
+3.49%
|
$63,600
$3.72 P/Share
|
|
Nov 02
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+1.21%
|
$30,000
$3.7 P/Share
|
|
Oct 29
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400
+0.1%
|
$1,600
$4.0 P/Share
|
|
Oct 28
2020
|
Osmium Partners, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400
+0.23%
|
$800
$2.9 P/Share
|